Welcome to chemicalbook!
+1 (818) 612-2111
RFQ
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

RFQ
skype
MY Account
Top
Postion:Product Catalog >Biochemical Engineering>Inhibitors>Lumateperone
Lumateperone
  • Lumateperone

Lumateperone NEW

Price $33 $48 $64
Package 10mg 25mg 50mg
Min. Order:
Supply Ability: 10g
Update Time: 2025-04-29

Product Details

Product Name: Lumateperone CAS No.: 313368-91-1
Purity: 99.77% Supply Ability: 10g
Release date: 2025/04/29

Product Introduction

Bioactivity

NameLumateperone
DescriptionLumateperone (ITI 722) is a 5HT2A receptor antagonist and a dopamine receptor phosphoprotein modulator (DPPM).
In vivoITI-722 was evaluated in the rat quipazine head twitch model induced by quipazine which is a 5-HT2A agonist, ITI-722 have ED50 values of 0.12 mg/kg.
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility InformationDMSO : 3.93 mg/mL (9.99 mM), Sonication is recommended.
KeywordsSerotonin Receptor | schizophrenia | presynaptic D2 receptor | postsynaptic D2 receptor | Lumateperone | ITI-722 | ITI 007 | Inhibitor | inhibit | Dopamine Receptor | dopamine D1 receptor | 5-hydroxytryptamine Receptor | 5HTReceptor | 5-HT2A | 5-HT Receptor | 5HT Receptor
Inhibitors RelatedSerotonin hydrochloride | Alverine citrate | Olanzapine | Dapoxetine hydrochloride | Clozapine N-Oxide | D-Menthol | Amitriptyline hydrochloride | Cloperastine hydrochloride | Trazodone hydrochloride | Mianserin hydrochloride | Fluoxetine hydrochloride | Cinchonidine
Related Compound LibrariesFailed Clinical Trials Compound Library | Pain-Related Compound Library | Anti-Neurodegenerative Disease Compound Library | Bioactive Compound Library | Membrane Protein-targeted Compound Library | Anti-Cancer Clinical Compound Library | Inhibitor Library | Anti-Cancer Approved Drug Library | FDA-Approved Drug Library | Bioactive Compounds Library Max | GPCR Compound Library | Anti-Cancer Drug Library

Company Profile Introduction

Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers. TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.

You may like

Recommended supplier

Product name Price   Suppliers Update time
$0.00/10mg
VIP2Y
ShenZhen H&D Pharmaceutical Technology Co., LTD
2025-03-26
$0.00/1kg
VIP1Y
Wuhan Circle Star Chem-medical Technology Co.,Ltd
2025-01-03
$0.00/1gram
VIP3Y
Chengdu Aupone Pharmaceutical Co.Ltd.
2024-03-18
$0.00/1g
VIP3Y
shandong perfect biotechnology co.ltd
2023-08-01
  • Since: 2011-01-07
  • Address: 36 Washington Street, Wellesley Hill, MA
INQUIRY